http://www.mmm-online.com/commercial-support/topic/2006/ Articles tagged with Commercial Support from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no New transparency rules set to lay bare financial ties between physicians and pharma will be a mixed bag for medical education, providers say. http://www.mmm-online.com/sunshine-spawns-fresh-questions-for-med-ed/article/280966/ Tue, 19 Feb 2013 20:40:16 GMT New transparency rules set to lay bare financial ties between physicians and pharma will be a mixed bag for medical education, providers say. MMM Data show detailing pressure and pharmaceutical rep access are still much higher in primary care than in other specialties. http://www.mmm-online.com/gps-harried-by-reps-oncologists-not-as-much/article/256741/ Thu, 30 Aug 2012 16:30:00 GMT Data show detailing pressure and pharmaceutical rep access are still much higher in primary care than in other specialties. MMM The drug industry dialed back its continuing medical education (CME) grant-giving in 2011, continuing a negative trend of the last few years. http://www.mmm-online.com/pharma-slashed-cme-funding-again-last-year-report/article/251878/ Wed, 25 Jul 2012 18:08:06 GMT The drug industry dialed back its continuing medical education (CME) grant-giving in 2011, continuing a negative trend of the last few years. MMM The FDA's opioid REMS safety plan is challenged on two fronts: getting CME providers to offer courses and getting doctors to attend them. Can the agency's scheme educate enough physicians to curb an epidemic? http://www.mmm-online.com/fda-opioid-plan-directs-funding-for-cme/article/249828/ Wed, 11 Jul 2012 17:08:41 GMT The FDA's opioid REMS safety plan is challenged on two fronts: getting CME providers to offer courses and getting doctors to attend them. Can the agency's scheme educate enough physicians to curb an epidemic? MMM Over the last four years, drugmakers have slashed support for samples as they rethink what once was an essential part of their marketing mix. http://www.mmm-online.com/samples-no-longer-hold-sway-in-pharma-marketing-mix-study/article/228680/ Tue, 21 Feb 2012 21:14:31 GMT Over the last four years, drugmakers have slashed support for samples as they rethink what once was an essential part of their marketing mix. MMM The ACCME awarded provisional two-year accreditation to Lighthouse Learning, the educational content provider which develops and sells CME curricula without accepting commercial funding. http://www.mmm-online.com/company-news-lighthouse-learning-and-shire/article/210884/ Tue, 30 Aug 2011 18:08:16 GMT The ACCME awarded provisional two-year accreditation to Lighthouse Learning, the educational content provider which develops and sells CME curricula without accepting commercial funding. MMM The drug industry's backing of certified CME fell for a third straight year, as registration fees and other income surged, just-released data from ACCME show. http://www.mmm-online.com/doctors-chip-in-more-for-cme-drugmakers-less-report/article/209504/ Fri, 12 Aug 2011 16:17:26 GMT The drug industry's backing of certified CME fell for a third straight year, as registration fees and other income surged, just-released data from ACCME show. MMM In a sign of industry's ongoing desire to broaden its CME funding outlook, a couple of recently supported educational programs by Pfizer aim to foster practice-based improvement as they seek to advance the science of CME. http://www.mmm-online.com/recent-pfizer-cme-grants-take-non-clinical-approach/article/209427/ Thu, 11 Aug 2011 13:15:42 GMT In a sign of industry's ongoing desire to broaden its CME funding outlook, a couple of recently supported educational programs by Pfizer aim to foster practice-based improvement as they seek to advance the science of CME. MMM A medical society that suggested using pooled funds to handle commercial support for medical education got an earful from industry. http://www.mmm-online.com/idea-for-generic-cme-fund-meets-with-skepticism/article/198353/ Tue, 15 Mar 2011 14:08:10 GMT A medical society that suggested using pooled funds to handle commercial support for medical education got an earful from industry. MMM Progenics announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation, to Salix Pharmaceuticals, beginning in April. Financial terms include a $60 million upfront payment to Progenics, and another potential $290 million in development and sales-based milestone payments. http://www.mmm-online.com/progenics-shifts-relistor-marketing-duties-from-pfizer-to-salix/article/195914/ Tue, 08 Feb 2011 18:52:33 GMT Progenics announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation, to Salix Pharmaceuticals, beginning in April. Financial terms include a $60 million upfront payment to Progenics, and another potential $290 million in development and sales-based milestone payments. MMM